SUN-Farmsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-12-18
Share capital
920 950,00 PLN
Activity description

SUN-Farm provides information for doctors, pharmacists and patients about medicinal products and OTC products. Its portfolio includes Psotriol, Vitaminum B12-SF, Verrucutan, Trimesan, Thyrosan, Rectodelt, Solacutan, Salbetan and Predasol; the company also accepts reports of adverse drug reactions.

Registered address
ul. Dolna 21, 05-092 Łomianki, Poland
Website
Phone
Electronic delivery address
AE:PL-44072-65911-FAFCR-27

Financials

Revenue history (in m)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. All were audited by a statutory auditor.

  • 2025not filed
  • 202420/03/2025
  • 202313/02/2024
  • 202228/06/2023
  • 202102/03/2022
  • 202003/03/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 51.06mMedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD 19.71mMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 26.03mMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 38.91mMedianUSD 883.09kAverageUSD 31.39m

Offer

  • Prescription medicines
  • Over-the-counter medicines
  • Dietary supplements
  • Medical devices
  • Cosmetics
  • Contract pharmaceutical manufacturing

Public procurement

SUN-Farm is the contractor in 26 public sector contracts, worth USD 5.21k in total. They were signed with 19 public buyers. The largest number (3) were signed with Wojewódzki Zespół Specjalistyczny w Rzeszowie.

SubjectAmount
zakup lancetów do testów skórnych
$27.01
Purchase of medicines
$275.80
Supply of skin tests
$162.07

Trademarks

SUN-Farm holds 33 active trademarks registered with the Polish Patent Office. 14 marks have expired or were not registered. The first mark was filed in 1992.

MarkNumberClassesStatusProtected until
sun farmZ.5242573, 5, 35, 40Protected Feb 5, 2031
SF(word)Z.5242553, 5, 35, 40Protected Feb 5, 2031
CALCIPREV(word)Z.3860405Protected May 31, 2031
CALDIPrevZ.3840235Protected Apr 12, 2031
CALDIPREV(word)Z.3840165Protected Apr 12, 2031
MarkProtected until
sun farmFeb 5, 2031
SF(word)Feb 5, 2031
CALCIPREV(word)May 31, 2031
CALDIPrevApr 12, 2031
CALDIPREV(word)Apr 12, 2031

Authorized Representatives

Andreas Eberhorn – President of the Management Board
Robert Kurecki – Management Board Member
Marcin Ocypa – Attorney-in-fact (sole)

Manner of representation

Each member of the management board independently.

Ownership

OwnerShare valueStake
Dermapharm Ag
$248,770.93100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1999-08-25.

  • mBank
    06 1140 1225 0000 5501 9600 1005
  • mBank
    60 1140 1225 0000 5501 9600 1003
  • mBank
    87 1140 1225 0000 5501 9600 1002

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$532.8K
Buildings and premises
$1.2M

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
BiotonS.A.
Celon PharmaS.A.
VercoS.A.
VipharmS.A.
MedicofarmaS.A.
VitamaS.A.
Munar PharmaS.A.
Sanford Biotechsp. z o.o.
Cefeasp. z o.o.
Auxilius PharmaS.A.

Change history

DateEvent
2015-05-08Address change
2015-05-08Name change
2002-12-20Share capital change
2002-11-26Address change
2001-12-18Entered in the register

FAQ

Last updated: 2026-10-07